EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recommendations for the follow-up of patients with cardiovascular disease when administering potentially effective medications for the treatment of COVID-19 with a purpose to reduce the risk of QT prolongation and sudden cardiac death

Iskren Garvanski, Ivo Petrov, Iana Simova

Bulgarian Cardiology · 2020

DOI: 10.3897/bgcardio.26.e52960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulgarian Cardiology, 2020. Verfasst von Iskren Garvanski und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the rising incidence and wider spread of the COVID-19 pandemic worldwide, it is of great importance to safely use potentially effective medicines to treat the infection. In recent weeks, a number of publications have emerged describing the likely effect of the use of known drugs, including chloroquine and hydroxychloroquine, and their combination with azithromycin. One of the most serious risks associated with the use of these medications is the drug-induced QT prolongation, which in turn increases the risk of developing torsades de pointes (TdP) and sudden cardiac death (SCD). In this document, we describe an approach to screen patients and monitor them with the aim to reduce the risk of drug-induced side effects.

Zitieren

APA

Garvanski, I., Petrov, I., & Simova, I. (2020). Recommendations for the follow-up of patients with cardiovascular disease when administering potentially effective medications for the treatment of COVID-19 with a purpose to reduce the risk of QT prolongation and sudden cardiac death. Bulgarian Cardiology. https://doi.org/10.3897/bgcardio.26.e52960

Vancouver

Garvanski I, Petrov I, Simova I. Recommendations for the follow-up of patients with cardiovascular disease when administering potentially effective medications for the treatment of COVID-19 with a purpose to reduce the risk of QT prolongation and sudden cardiac death. Bulgarian Cardiology. 2020. doi:10.3897/bgcardio.26.e52960

BibTeX
@article{Garvanski2020,
  author = {Garvanski, Iskren and Petrov, Ivo and Simova, Iana},
  title = {Recommendations for the follow-up of patients with cardiovascular disease when administering potentially effective medications for the treatment of COVID-19 with a purpose to reduce the risk of QT prolongation and sudden cardiac death},
  journal = {Bulgarian Cardiology},
  year = {2020},
  doi = {10.3897/bgcardio.26.e52960}
}
Kostenlos starten →